Market Overview

I think you’ll love what you hear,
what you’ll see and the opportunities
that will be set before you.
- Jon Najarian
GET TICKETS

Barrington Research Initiates Coverage On Healthways, Cites Strong Macro Environment

Share:

Michael Petusky of Barrington Research on Thursday initiated coverage of Healthways, Inc. (NASDAQ: HWAY) with an Outperform rating and $25 price target as the company stands to benefit from a strong macro environment.

“The estimated addressable market size for the population health management industry is estimated to be approximately $50 billion,” Petusky wrote. “Growth in the market is primarily being fueled by the aging of the population, the increased prevalence of chronic diseases, the impact of the Affordable Care Act, and the shifting of financial risk.”

Petusky adds that the positive environment will remain in place for the foreseeable future and that the company has established a reputation of being a “safe bet” with a proven track record.

The analyst adds that the company maintains a customer retention rate of 90 percent plus that only reinforces a bullish thesis.

Shares of Healthways recently traded at $18.70, up 2.6 percent.

Latest Ratings for HWAY

DateFirmActionFromTo
Jan 2017UpgradesHoldBuy
Nov 2016UpgradesSellBuy
Aug 2016DowngradesNeutralSell

View More Analyst Ratings for HWAY
View the Latest Analyst Ratings

Posted-In: Affordable Care Act Barrington Research health care healthways Michael PetuskyAnalyst Color Initiation Analyst Ratings

 

Related Articles (HWAY)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
ORCLMaintains59.0
ORCLMaintains61.0
FDXMaintains200.0
ORCLMaintains59.0
ACNMaintains186.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Stocks Hitting 52-Week Highs

Why Leerink Sees Further Upside In Shares Of UnitedHealth